The clinical management of BRCA1 and BRCA2 mutation carriers (Q22252596)

4 August 2017

1 reference

title

The clinical management of BRCA1 and BRCA2 mutation carriers (English)

1 reference

4 August 2017

1 reference

1 reference

2

Susan M. Domchek

0 references

Susan M Domchek

series ordinal

2

object named as

Susan M Domchek

1 reference

4 August 2017

Anthony P. Gulati

1

0 references

Anthony P Gulati

series ordinal

1

1 reference

4 August 2017

January 2008

0 references

1 January 2008

1 reference

4 August 2017

Current Oncology Reports

2 references

Crossref

4 August 2017

10

1 reference

4 August 2017

47-53

1 reference

4 August 2017

1

1 reference

https://scigraph.springernature.com/pub.10.1007/s11912-008-0008-9

4 August 2017

0 references

cites work

Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11912-008-0008-9

Gynecologic Surgeries and Risk of Ovarian Cancer in Women With BRCA1 and BRCA2 Ashkenazi Founder Mutations: An Israeli Population-Based Case-Control Study

21 January 2018

1 reference

12 December 2020

Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study.

1 reference

12 December 2020

Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation

1 reference

12 December 2020

Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study

1 reference

12 December 2020

Screening mammography and risk of breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study.

1 reference

12 December 2020

Cancer susceptibility and the functions of BRCA1 and BRCA2

1 reference

12 December 2020

The role of BRCA1 in the cellular response to chemotherapy

1 reference

12 December 2020

Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial

1 reference

12 December 2020

Radiation and breast cancer: a review of current evidence

1 reference

12 December 2020

The roles of BRCA1 and BRCA2 and associated proteins in the maintenance of genomic stability

1 reference

12 December 2020

Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation.

1 reference

12 December 2020

Effect of mammography on breast cancer risk in women with mutations in BRCA1 or BRCA2.

1 reference

12 December 2020

Surveillance of women at high risk for hereditary ovarian cancer is inefficient

1 reference

12 December 2020

Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition

1 reference

12 December 2020

Occult ovarian tumors in women with BRCA1 or BRCA2 mutations undergoing prophylactic oophorectomy

1 reference

12 December 2020

Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination.

1 reference

12 December 2020

Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS).

1 reference

12 December 2020

Clinical outcomes of breast cancer in carriers of BRCA1 and BRCA2 mutations

1 reference

12 December 2020

Oral contraceptives and the risk of hereditary ovarian cancer. Hereditary Ovarian Cancer Clinical Study Group.

1 reference

12 December 2020

Prophylactic Oophorectomy Reduces Breast Cancer Penetrance During Prospective, Long-Term Follow-Up ofBRCA1Mutation Carriers

1 reference

12 December 2020

CA125 and transvaginal ultrasound monitoring in high-risk women cannot prevent the diagnosis of advanced ovarian cancer

1 reference

12 December 2020

Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers

1 reference

12 December 2020

Incidence of female breast cancer among atomic bomb survivors, Hiroshima and Nagasaki, 1950-1990

1 reference

12 December 2020

Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer.

1 reference

12 December 2020

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

1 reference

12 December 2020

Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: an update

1 reference

12 December 2020

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

1 reference

12 December 2020

Ten-Year Multi-Institutional Results of Breast-Conserving Surgery and Radiotherapy inBRCA1/2-Associated Stage I/II Breast Cancer

1 reference

12 December 2020

Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial.

1 reference

12 December 2020

Medical radiation exposure and breast cancer risk: findings from the Breast Cancer Family Registry

1 reference

12 December 2020

Effect of Short-Term Hormone Replacement Therapy on Breast Cancer Risk Reduction After Bilateral Prophylactic Oophorectomy in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study Group

1 reference

12 December 2020

Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2

1 reference

12 December 2020

Improved survival in women with BRCA-associated ovarian carcinoma

1 reference

12 December 2020

Oral contraceptives and breast cancer risk in the international BRCA1/2 carrier cohort study: a report from EMBRACE, GENEPSO, GEO-HEBON, and the IBCCS Collaborating Group

1 reference

12 December 2020

Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations

1 reference

12 December 2020

The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2.

1 reference

12 December 2020

Efficacy of Bilateral Prophylactic Mastectomy in Women with a Family History of Breast Cancer

1 reference

12 December 2020

Effect of Radiotherapy After Breast-Conserving Treatment in Women With Breast Cancer and Germline BRCA1/2 Mutations

1 reference

12 December 2020

Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group

1 reference

12 December 2020

Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group

1 reference

12 December 2020

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

1 reference

12 December 2020

Reproductive risk factors for ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study

1 reference

12 December 2020

Effect of chest X-rays on the risk of breast cancer among BRCA1/2 mutation carriers in the international BRCA1/2 carrier cohort study: a report from the EMBRACE, GENEPSO, GEO-HEBON, and IBCCS Collaborators' Group.

1 reference

12 December 2020

Oral contraceptive use and ovarian cancer risk among carriers of BRCA1 or BRCA2 mutations

1 reference

12 December 2020

Impact of BRCA1/BRCA2 counseling and testing on newly diagnosed breast cancer patients

1 reference

12 December 2020

Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studies

1 reference

12 December 2020

BRCA1 and BRCA2 mutation carriers, oral contraceptive use, and breast cancer before age 50.

1 reference

12 December 2020

Efficacy of screening women at high risk of hereditary ovarian cancer: results of an 11-year cohort study

1 reference

12 December 2020

10.1007/S11912-008-0008-9

Identifiers

DOI

1 reference

PubMed ID

18366960

Dimensions Publication ID

4 August 2017

0 references

1 reference

PubMed ID

18366960